Switch theme
Sign up to access all valuation multiples
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
2023
32.4K+
LTM Revenue $4.2B
LTM EBITDA $414M
$4.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
PACS Group has a last 12-month revenue (LTM) of $4.2B and a last 12-month EBITDA of $414M.
In the most recent fiscal year, PACS Group achieved revenue of $3.1B and an EBITDA of $233M.
PACS Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See PACS Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | XXX | $3.1B | XXX | XXX | XXX |
| Gross Profit | $966M | XXX | $447M | XXX | XXX | XXX |
| Gross Margin | 23% | XXX | 14% | XXX | XXX | XXX |
| EBITDA | $414M | XXX | $233M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 7% | XXX | XXX | XXX |
| EBIT | $376M | XXX | $208M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $256M | XXX | $113M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $659M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, PACS Group's stock price is $10.
PACS Group has current market cap of $1.5B, and EV of $4.1B.
See PACS Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.1B | $1.5B | XXX | XXX | XXX | XXX | $1.71 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, PACS Group has market cap of $1.5B and EV of $4.1B.
PACS Group's trades at 1.3x EV/Revenue multiple, and 17.8x EV/EBITDA.
Equity research analysts estimate PACS Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
PACS Group has a P/E ratio of 6.0x.
See valuation multiples for PACS Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV (current) | $4.1B | XXX | $4.1B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 10.0x | XXX | 17.8x | XXX | XXX | XXX |
| EV/EBIT | 11.0x | XXX | 19.9x | XXX | XXX | XXX |
| EV/Gross Profit | 4.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 6.0x | XXX | 13.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -37.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPACS Group's last 12 month revenue growth is 13%
PACS Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $7K for the same period.
PACS Group's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
PACS Group's rule of X is 41% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for PACS Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | 18% | XXX | 35% | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 41% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $7K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
PACS Group acquired XXX companies to date.
Last acquisition by PACS Group was XXXXXXXX, XXXXX XXXXX XXXXXX . PACS Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was PACS Group founded? | PACS Group was founded in 2023. |
| Where is PACS Group headquartered? | PACS Group is headquartered in United States of America. |
| How many employees does PACS Group have? | As of today, PACS Group has 32.4K+ employees. |
| Who is the CEO of PACS Group? | PACS Group's CEO is Mr. Jason Murray. |
| Is PACS Group publicy listed? | Yes, PACS Group is a public company listed on NYS. |
| What is the stock symbol of PACS Group? | PACS Group trades under PACS ticker. |
| When did PACS Group go public? | PACS Group went public in 2024. |
| Who are competitors of PACS Group? | Similar companies to PACS Group include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of PACS Group? | PACS Group's current market cap is $1.5B |
| What is the current revenue of PACS Group? | PACS Group's last 12 months revenue is $4.2B. |
| What is the current revenue growth of PACS Group? | PACS Group revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of PACS Group? | Current revenue multiple of PACS Group is 1.0x. |
| Is PACS Group profitable? | Yes, PACS Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of PACS Group? | PACS Group's last 12 months EBITDA is $414M. |
| What is PACS Group's EBITDA margin? | PACS Group's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of PACS Group? | Current EBITDA multiple of PACS Group is 10.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
